ALK and anaplastic large cell lymphoma: Since alectinb was more effective than crizotinib at inhibiting the growth of ALK+ ALCL cell lines in our in vitro experiments (Figure 2), we decided to focus on it for the remainder of the study and test it in combination with DNA-demethylating agents.